Media and Investors Resources

Press Release, 28 November 2023

Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages

Press Release, 12 October 2023

Adhoc Press Release

Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management

Press Release, 9 August 2023

Adhoc Press Release

Kuros Biosciences Reports Results for First Half 2023

Kuros Interim Results, 2023

English version

Press Release, 13 July 2023

Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial

Minutes of the AGM, 8 May 2023

German version